-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Dupilumab in Systemic Sclerosis (Scleroderma)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Dupilumab in Systemic Sclerosis (Scleroderma) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Dupilumab in Systemic Sclerosis (Scleroderma) Drug Details: Dupilumab (REGN-668, SAR231893,...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Dupilumab in Chronic Obstructive Pulmonary Disease (COPD)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Dupilumab in Chronic Obstructive Pulmonary Disease (COPD) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Dupilumab in Chronic Obstructive Pulmonary Disease (COPD) Drug...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – RD-07 in Pancreatic Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - RD-07 in Pancreatic Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. RD-07 in Pancreatic Cancer Drug Details: RD-07 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – RD-07 in Adenocarcinoma Of The Gastroesophageal Junction
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - RD-07 in Adenocarcinoma Of The Gastroesophageal Junction report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. RD-07 in Adenocarcinoma Of The Gastroesophageal Junction Drug Details:...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Abatacept in Myocarditis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Abatacept in Myocarditis report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Abatacept in Myocarditis Drug Details: Abatacept (Orencia/ Ohrencia) is a soluble fusion...
-
Product Insights
Likelihood of Approval Analysis for Respiratory Distress Syndrome
Overview How likely is it that the drugs in Respiratory Distress Syndrome will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Respiratory Distress Syndrome Overview Respiratory distress syndrome (RDS) occurs in babies...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – BR-1018 in Hypercholesterolemia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - BR-1018 in Hypercholesterolemia report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. BR-1018 in Hypercholesterolemia Drug Details: BR-1018 is under development for treatment of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – BGB-3245 in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - BGB-3245 in Solid Tumor report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. BGB-3245 in Solid Tumor Drug Details: BGB-3245 is under development for...
-
Product Insights
FWHS/ JPI Dev – Jefferson Eastchase Apartment Community – Texas
The FWHS/ JPI Dev – Jefferson Eastchase Apartment Community – Texas involves the construction of a 398 units apartment community at 8101 Ederville Rd, Fort Worth, Texas, the US. Equip yourself with the essential tools needed to make informed and profitable decisions with our FWHS/ JPI Dev – Jefferson Eastchase Apartment Community – Texas report. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business days of the...